Cargando…
THU267 A Novel In Vitro Assay Correlates Insulin Receptor Autoantibodies To Fasting Insulin In Type B Insulin Resistance
Disclosure: B. Abel: None. W. Minich: Stock Owner; Self; ImmunometriX GmbH. C. Schwiebert: Employee; Self; Bruker Corporation. T. Welsink: Employee; Self; Bruker Corporation. P. Seemann: Stock Owner; Self; ImmunometriX GmbH, selenOmed GmbH. L. Schomburg: Stock Owner; Self; selenOmed GmbH. R.J. Brown...
Autores principales: | Abel, Brent, Minich, Waldemar, Schwiebert, Christian, Welsink, Tim, Seemann, Petra, Schomburg, Lutz, Brown, Rebecca J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553733/ http://dx.doi.org/10.1210/jendso/bvad114.703 |
Ejemplares similares
-
THU350 Rapid Decrease Of Glycemic Levels In Three Patients With Severe Insulin Resistance Associated With Bell’s Palsy.
por: Chuki, Elias, et al.
Publicado: (2023) -
THU268 Hyperuricemia In Insulin Resistance Is Associated With Increased Synthesis And Not Decreased Renal Excretion Of Uric Acid In Humans
por: Haykal, Rasha, et al.
Publicado: (2023) -
THU392 Type B Insulin Resistance: A Rare Cause Of Hypoglycemia
por: Zahoor Bhat, Salman, et al.
Publicado: (2023) -
Antagonistic Autoantibodies to Insulin-Like Growth Factor-1 Receptor Associate with Poor Physical Strength
por: Schwiebert, Christian, et al.
Publicado: (2020) -
THU335 Hyperinsulinemia Is Associated With An Atherogenic Lipoprotein Profile In Humans With Selective Insulin Resistance And An Atheroprotective Profile In Humans With Non-selective Insulin Resistance
por: Walzer, Dalia, et al.
Publicado: (2023)